Borderline Personality Disorder (BPD) is under-recognized in First-Episode Psychosis (FEP) and its psychotic manifestations are difficult to diferentiate from Schizophrenia Spectrum Disorders (SSD). The aim of this investigation was to compare clinical, sociodemographic, and outcome characteristics between FEP patients with BPD vs. FEP subjects with SSD both at baseline and across a 2-year follow-up period. Participants completed the Health of the Nation Outcome Scale (HoNOS), the Positive And Negative Syndrome Scale (PANSS), and the Global Assessment of Functioning (GAF) scale both at entry and every 12 months during the follow-up. A mixed-design ANOVA model was conducted to investigate the temporal stability of clinical scores within and between the two subgroups. Among 356 FEP participants, 49 had a BPD diagnosis. Compared to FEP/SSD (n=307), FEP/BPD patients showed higher prevalence of employment, current substance use, and past ttempted suicide. They had a lower equivalent dose of antipsychotic medication at entry and lower levels of negative symptoms. Finally, they had a higher 2-year drop-out rate and a signifcant improvement in psychopathological scores limited to the frst year of treatment. BPD as categorical entity represents a FEP subgroup with specifc clinical challenges. Appropriate treatment guidelines for this FEP subgroup are thus needed.
Lorenzo Pelizza, E.L. (2024). Borderline personality disorder vs. schizophrenia spectrum disorders in young people recruited within an “Early Intervention in Psychosis” service: clinical and outcome comparisons. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 0, 1-13 [10.1007/s00406-024-01772-5].
Borderline personality disorder vs. schizophrenia spectrum disorders in young people recruited within an “Early Intervention in Psychosis” service: clinical and outcome comparisons.
Lorenzo Pelizza
Primo
;Lorenzo Gammino;Arianna Biancalani;Marco MenchettiUltimo
2024
Abstract
Borderline Personality Disorder (BPD) is under-recognized in First-Episode Psychosis (FEP) and its psychotic manifestations are difficult to diferentiate from Schizophrenia Spectrum Disorders (SSD). The aim of this investigation was to compare clinical, sociodemographic, and outcome characteristics between FEP patients with BPD vs. FEP subjects with SSD both at baseline and across a 2-year follow-up period. Participants completed the Health of the Nation Outcome Scale (HoNOS), the Positive And Negative Syndrome Scale (PANSS), and the Global Assessment of Functioning (GAF) scale both at entry and every 12 months during the follow-up. A mixed-design ANOVA model was conducted to investigate the temporal stability of clinical scores within and between the two subgroups. Among 356 FEP participants, 49 had a BPD diagnosis. Compared to FEP/SSD (n=307), FEP/BPD patients showed higher prevalence of employment, current substance use, and past ttempted suicide. They had a lower equivalent dose of antipsychotic medication at entry and lower levels of negative symptoms. Finally, they had a higher 2-year drop-out rate and a signifcant improvement in psychopathological scores limited to the frst year of treatment. BPD as categorical entity represents a FEP subgroup with specifc clinical challenges. Appropriate treatment guidelines for this FEP subgroup are thus needed.File | Dimensione | Formato | |
---|---|---|---|
Pelizza_2024.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
704.52 kB
Formato
Adobe PDF
|
704.52 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.